BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. scores highest on Torque (96) and lowest on Price (0). Its PosiPenta is 53.98 out of 100, around the middle of similar companies.
On the Penta Grid this week, BridgeBio Pharma, Inc. is Grid #229 of 837 in the Healthcare sector in United States, and Grid #1,401 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | 53.98 | 0 | 48 | 67 | 96 | 60 |
| Baxter International Inc. | 56.40 | 28 | 62 | 84 | 41 | 67 |
| Penumbra, Inc. | 60.59 | 15 | 74 | 87 | 66 | 62 |
| Halozyme Therapeutics, Inc. | 62.50 | 17 | 91 | 99 | 50 | 55 |
| Encompass Health Corporation | 65.95 | 43 | 61 | 98 | 57 | 70 |
| Summit Therapeutics Inc. | 36.34 | 3 | 34 | 45 | 40 | 59 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -18.65 |
| P/B ratio | -5.16 |
EEarnings
| Trailing EPS | ₹-337.19 |
| Forward EPS | ₹-24.19 |
NNitro
| Price | 6288.13 |
| 52-week high | 8847.80 |
| 52-week low | 4996.21 |
| Fall from 52-week high | 28.9% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.89 |
AAnchor
| Beta (price swings) | 0.97 |
| Market cap | ₹1,22,928 Cr |
| Insider holding | 3.91% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is BridgeBio Pharma, Inc.'s PosiPenta score?
BridgeBio Pharma, Inc.'s PosiPenta is 53.98 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does BridgeBio Pharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, BridgeBio Pharma, Inc. is Grid #229 of 837 in the Healthcare sector in United States, and Grid #1,401 of 4,000 in United States.
Which PosiPenta pillar is strongest for BridgeBio Pharma, Inc.?
Torque (durability), with a score of 96 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for BridgeBio Pharma, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has BridgeBio Pharma, Inc.'s PosiPenta changed since last week?
Yes, it rose 12.85 points, from 41.13 to 53.98.
PositoAI is for research and education only and is not investment advice.